Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

All articles

Showing 241–252 of 411 articles

  • Interpret the evidence

    Why a trial of a different tripeptide cannot answer for KPV

    KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An older randomized study in people with ulcerative colitis investigated a separate three-amino-acid molecule called K(D)PT. The similar names can obscure which peptide was actually tested.

    KPV3 sources (2007–2026)

  • Explore study findings

    Why Lipopeptide Names a Class Rather Than One Substance

    A lipopeptide has both a peptide component and a lipid component. Lipids interact differently with water than many peptide chains do, so joining the two can influence where the material goes or how it assembles.

    Lipopeptide2 sources (2026)

  • Check methods and identity

    What Collagen Measurements Showed for Two Palmitoyl Peptides

    Adding a fatty-acid part creates a lipopeptide, but the amino-acid portion still affects the material's behavior. A 2026 study of two palmitoyl pentapeptides, or lipid-linked chains of five amino acids, compared their effects on skin-related cell measurements.

    Lipopeptide1 source (2026)

  • Explore study findings

    Why Some Lipopeptides Form Tapes and Others Form Micelles

    A 2026 study compared how two defined lipopeptides formed such structures. Lucas de Mello and colleagues examined a palmitoyl pentapeptide used in cosmetic research and a related compound with changes in its charged amino acids. They compared the two in different salt forms and environments.

    Lipopeptide1 source (2026)

  • Understand the science

    How Lipopeptides Were Studied as Part of a Skin Delivery System

    Lipopeptides add a lipid component, which can affect interactions with a membrane or a carrier. A 2026 psoriasis study used engineered lipopeptides as part of a delivery system. It illustrates the difference between a carrier and the substance intended to act on a target.

    Lipopeptide1 source (2026)

  • Explore study findings

    What a Skin Immunity Study Reveals About Bacterial Lipopeptides

    A chain with an attached lipid is one kind of lipopeptide, and microbes as well as laboratories can produce materials in this broad class. A 2026 study of bacterial lipopeptides asked how certain soluble materials affected a signal released by skin cells.

    Lipopeptide1 source (2026)

  • Check methods and identity

    What a Human Wrinkle Study Tested for One Palmitoyl Lipopeptide

    A peptide is a short chain of amino acids joined by peptide bonds. Adding a lipid to that chain can change how a material behaves in a topical product. Palmitoyl pentapeptide, often abbreviated pal-KTTKS, is one specific example. It is not a synonym for the catalog term Lipopeptide.

    Lipopeptide2 sources (2005, 2026)

  • Interpret the evidence

    What pediatric clinic records add to the liraglutide evidence

    Liraglutide is a modified peptide that activates the glucagon-like peptide-1, or GLP-1, receptor. In 2026, investigators examined health records to see how blood sugar measures changed in young people with type 2 diabetes who received liraglutide in a clinical setting.

    Liraglutide3 sources (2025, 2026)

  • Check methods and identity

    Why a type 1 diabetes study measured C-peptide

    Liraglutide is a modified GLP-1 receptor agonist peptide. Its effects on blood glucose in type 2 diabetes led researchers to ask a narrower question in people with long-standing type 1 diabetes. Could the medicine preserve any insulin-making function that remained?

    Liraglutide2 sources (2025, 2026)

  • Explore study findings

    What exercise and liraglutide changed in a weight-maintenance study

    Liraglutide is a modified GLP-1 receptor agonist peptide. A 2026 analysis of the S-LiTE trial examined whether exercise, liraglutide or both changed measurements of blood vessel health after participants had already lost weight through a supervised program.

    Liraglutide1 source (2026)

  • Understand the science

    How a stroke trial explored insulin resistance

    Liraglutide is a peptide that activates the GLP-1 receptor. A 2026 analysis of the LAMP trial explored whether the association between liraglutide and recurrent stroke differed with participants’ starting insulin resistance.

    Liraglutide3 sources (2025, 2026)

  • Explore study findings

    Why a five-week body composition study reported amounts and percentages

    Liraglutide is a modified GLP-1 receptor agonist. A 2026 report from a small randomized study looked at how body composition changed during a short period, with special attention to the difference between the amount of lean tissue and its share of total body weight.

    Liraglutide1 source (2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)